EPTIS
BAM Logo

3 HLA Antibody specificity analysis

EPTIS factsheet 157892 | Last revision 2018-09-14 | URL: https://www.eptis.bam.de/pts157892 https://www.eptis.bam.de/pts157892

PT provider
PT provider UK NEQAS for Histocompatibility and Immunogenetics UK NEQAS for Histocompatibility and Immunogenetics
Based in United Kingdom
Language(s)
Remarks
Keywords
Product groups Human test material
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Human serum HLA Class I Antibodies ELISA
Flow cytometry
Bead array analysis
CDC
HLA Class II Antibodies ELISA
Flow cytometry
Bead array analysis
CDC
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards European Federation for Immunogenetics (EFI)
Additional, subsidiary aims
Number of participants
Accredited or otherwise reviewed by a 3rd party

Accredited by UKAS on the basis of ISO:17043

Operation is commissioned / requested by
Fees and frequency
Participation fee Contact provider for current price
Regularly operated Yes (2 times per annum)
Year of first operation 1991
Contact details of the PT provider
Provider Contact person
UK NEQAS for Histocompatibility and Immunogenetics
Ely Valley Road
CF72 9WB Pontyclun
United Kingdom

Phone: +44 (0) 1443 622185
Fax: +44 (0) 1443 622001
Web: http://www.ukneqashandi.org.uk http://www.ukneqashandi.org.uk
Mrs Deborah Pritchard
Phone: +44 (0) 1443 622185
Fax: +44 (0) 1443 622001
Email: ukneqashandi@wales.nhs.uk ukneqashandi@wales.nhs.uk
If you find any mistakes please contact the responsible EPTIS coordinator in United Kingdom, Mr Savvas Xystouris. Mr Savvas Xystouris.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21